Kirk G. Nielsen has bought stock on 6 days since Feb 2022

Kirk G. Nielsen is a seasoned venture capital executive and board director in the medtech sector. He serves as Managing Partner at Vensana Capital since January 2019, which he co-founded, and as Managing Director at Versant Ventures since January 2011, leading the firm's medtech practice.( Previously at Medtronic in Cardiac Rhythm Management sales and marketing, and earlier as a consultant at Bain & Company and professional hockey player, Nielsen holds an M.B.A. from Harvard Business School and an A.B. from Harvard College.(

Nielsen is a Director at SpyGlass Pharma, Inc. (SGP), where he recently purchased 165,000 shares on February 9, 2026, signaling confidence in the company.( He also serves as an independent director at CVRx, Inc. (CVRX) since July 2020 (Class III, NCG Committee Chair, Audit member), previously as Independent Lead Director until February 2024, and on boards of multiple medtech firms including Alleviant Medical, Elucent Medical, and others.( His investments include successful exits like Inari Medical (IPO) and SpyGlass Pharma.(

Written by Perplexity from public sources.